Deal Maker or Deal Breaker: Best Practices in Regulatory, IP, and Product Liability Due Diligence
As M&A and investment activity heat up in the medical devices and technology market, it is critical to identify a target company's existing or potential regulatory, IP and product liability risks and assess possible exposure. Through case studies and interactive presentations, this panel addressed a number of issues that companies and their counsel should consider when contemplating a merger or acquisition.
Developed by industry, for industry, AdvaMed 2007 is the premier medical technology conference and exhibition for business leaders, policymakers, patient groups, news media, financiers, and service providers from around the world.
On October 1-3, 2007, over 800 senior level executives representing more than 500 companies from 30 states and 15 countries converged on the largest political stage in the world, Washington, DC.
For three days, attendees participated in policy sessions, educational workshops, partnering and business development discussions, investor presentations, and product exhibitions.